3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Gastrointestinal
1
Conditions
Barrett Esophagus
13
Esophageal Neoplasms
7
Rectal Neoplasms
6
Colorectal Neoplasms
6
Adenocarcinoma Of Esophagus
6
Nasopharyngeal Carcinoma
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Polyps
3
Lung Neoplasms
3
Precancerous Conditions
2
Pathologic Complete Response
2
Hyperplasia
2
Gastroesophageal Reflux
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adenomatous Polyposis Coli
2
Adenocarcinoma
2
Urogenital Neoplasms
1
Upper Tract Urothelial Carcinoma
1
Thyroid Neoplasms
1
Stomach Ulcer
1
Stomach Diseases
1
Recurrence
1
Polyposis, Gastric
1
Ovarian Neoplasms
1
Nasopharyngeal Neoplasms
1
Metaplasia
1
Interventions
Cisplatin
55
Carboplatin
49
pembrolizumab
42
Paclitaxel
42
Gemcitabine
28
Pemetrexed
23
Radiotherapy
21
Magnetic Resonance Spectroscopy
20
Radiotherapy, Intensity-Modulated
18
Docetaxel
17
Cetuximab
17
Specimen Handling
16
Nivolumab
16
Fluorouracil
16
Cyclophosphamide
14
durvalumab
13
Bevacizumab
12
Radiation
11
Sorafenib
10
Platinum
10
130-nm albumin-bound paclitaxel
10
1,2-diaminocyclohexaneplatinum II citrate
10
osimertinib
9
Sunitinib
8
Oxaliplatin
8
Irinotecan
8
Ipilimumab
8
Everolimus
8
Drug Therapy
8
Capecitabine
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma
×
Endoscopy
×
Clear all
NCT05144100
2021-12-03
SCOPE
Tata Memorial Centre
Phase 2/3
Not yet recruiting
498 enrolled
NCT01727908
2019-09-16
FamGaCan
Radboud University Medical Center
Phase NA
Terminated
79 enrolled